Cleared Traditional

K926139 - CATHLINK 20 TITANIUM PORT W/ATT. POLYUR...

K926139 is the FDA 510(k) clearance for CATHLINK 20 TITANIUM PORT W/ATT. POLYUR... by Bard Access Systems, Inc.. It is a Class 2 General Hospital device (product code LJT) cleared through the Traditional 510(k) pathway after a 757-day FDA review.

K926139 · Bard Access Systems, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1995
Decision
757d
Days
Class 2
Risk

K926139 is an FDA 510(k) clearance for the CATHLINK 20 TITANIUM PORT W/ATT. POLYURETHANE CATH. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Bard Access Systems, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on January 3, 1995 after a review of 757 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Bard Access Systems, Inc. devices

Submission Details

510(k) Number K926139 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 07, 1992
Decision Date January 03, 1995
Days to Decision 757 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
628d slower than avg
Panel avg: 129d · This submission: 757d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 110
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K926139.
CELSITE VENOUS SYSTEM
K952548 · B.Braun Medical, Inc. · Jul 1995
STRATO MEDICAL LIFEPORT LPS 7515
K942848 · Strato Medical Corp. · Feb 1995
STRATO MEDICAL INFUSE-A-PORT/INFUSE-A-KIT PERIPORT PERIPHERAL ACCESS SYSTEM
K934518 · Strato Medical Corp. · Jan 1995
PORT-A-CATH LOW PROFILE IMPLANTABLE VENOUS ACCESS SYSTEM
K942024 · Pharmacia Deltec, Inc. · Jul 1994
IPI DUAL LUMEN PORT
K934167 · Pudenz-Schulte Medical Research Corp. · Jul 1994
IPI LOW PROFILE IMPORT
K934796 · Pudenz-Schulte Medical Research Corp. · Jul 1994